The Concepts, Diagnosis and Management of Early Imaging Changes after Therapy for Glioblastomas
Authors:
- R. RamplingRRR. Rampling
- 1 April 2012
- journal article
- review article
- Published by Elsevier in Clinical Oncology
- Vol. 24 (3) , 216-227
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Pseudoprogression Following Chemoradiotherapy for Glioblastoma MultiformeCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2010
- Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendationsSurgical Neurology, 2009
- Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed GlioblastomaJournal of Clinical Oncology, 2009
- Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progressionJournal of Neuro-Oncology, 2009
- Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomideCancer, 2008
- MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma PatientsJournal of Clinical Oncology, 2008
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Immediate post-radiotherapy changes in malignant glioma can mimic tumor progressionNeurology, 2004
- Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem gliomaMedical and Pediatric Oncology, 1991
- Reversible Oedema and Necrosis after Irradiation of the Brain Diagnostic Procedures and Clinical ManifestationsActa Oncologica, 1990